Skip to main content
Log in

Universal prenatal hepatitis C screening cost effective in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

Reference

  • Tasillo A, et al. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstetrics and Gynecology : 8 Jan 2019. Available from: URL: http://doi.org/10.1097/AOG.0000000000003062

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Universal prenatal hepatitis C screening cost effective in USA. PharmacoEcon Outcomes News 821, 32 (2019). https://doi.org/10.1007/s40274-019-5649-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5649-4

Navigation